| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/30/2008 | CN100384439C Medicinal composition for treating and/or preventing heart brnin blood vessel disease and its preparation method |
| 04/30/2008 | CN100384436C Parenteral cisplatin emulsion |
| 04/30/2008 | CN100384435C Saline solution for treating nasal cavity disease and its application device |
| 04/30/2008 | CN100384434C Gel containing betulaprenol from ginkgo leaves and its preparing method |
| 04/30/2008 | CN100384431C Traditional Chinese medicine compositions |
| 04/30/2008 | CN100384429C Capsule for treating cardiac and cerebral vascular diseases and its preparing method and application |
| 04/30/2008 | CN100384428C Oral disintegrating tablet of notoginseng triterpenes and preparation method thereof |
| 04/30/2008 | CN100384427C Injection preparation containing active component adefuwei or its salt and its preparation method |
| 04/30/2008 | CN100384426C Solid dispersion containing active component adefuwei or its salt and its preparation method |
| 04/30/2008 | CN100384422C Anti-microbial composition comprising a metal ion chelating agent |
| 04/30/2008 | CN100384419C Epothilone slow-release implanting composition and use |
| 04/30/2008 | CN100384416C Medicinal composition for treating cerebrovascular disease |
| 04/30/2008 | CN100384415C Preparation method of magnetic nanometer granule containing mitocin-C |
| 04/30/2008 | CN100384411C Oral carbidopa/levodopa disintegrant tablet |
| 04/30/2008 | CN100384410C Parenteral dosage forms comprising suspension of tramadol salt and diclofenac salt |
| 04/30/2008 | CN100384408C Novel composition |
| 04/30/2008 | CN100384407C Chinese medicine oral cavity adherent emplastrum and its preparation method |
| 04/30/2008 | CN100384406C Coating method for microcapsule of lysine hydrochloride |
| 04/30/2008 | CN100384405C Hepatitis B support right fast dispersion solid preparation and its preparation method |
| 04/30/2008 | CN100384404C Jinsuo emission-arresting fast dispersing solid preparation and its preparation method |
| 04/30/2008 | CN100384403C Body building fetus quieting fast aispersion solid preparation and its preparation method |
| 04/30/2008 | CN100384402C Jinsang sanjie fast dispersion solid preparation for treating throat and its preparation method |
| 04/30/2008 | CN100384401C Kunbao (female treasure) fast dispersion solid preparation and its preparation method |
| 04/30/2008 | CN100384400C Small golden pellets and preparation method |
| 04/30/2008 | CN100384399C Temperature controllable heat therapeutic embolizing sponge powder an its preparation process |
| 04/30/2008 | CN100384398C Base for oral composition and the oral composition |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365051 Compounds with improved cartilage-inducing and/or bone-inducing activity |
| 04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
| 04/29/2008 | US7364888 Intratracheal administration of lysozyme with other therapeutic agents in the prevention and treatment of respiratory disorders |
| 04/29/2008 | US7364764 Soluble roasted chicory having high inulin content |
| 04/29/2008 | US7364755 Modified calcium phosphate excipient |
| 04/29/2008 | US7364754 Preparing micelles entrapping photosensitive drugs; adding alkoxyorganosilane to the micelles to form complexes of silica and the micelles; subjecting the complexes of silica and micelles to alkaline hydrolysis to precipitate silica nanoparticles; isolating the precipitated nanoparticles by dialysis |
| 04/29/2008 | US7364753 Magnesium-containing compositions and methods for enhancing dehydroepiandrosterone levels |
| 04/29/2008 | US7364752 Solid dispersion pharamaceutical formulations |
| 04/29/2008 | US7364751 By adding an antioxidant and/or a chelating agent in the same aqueous solution; reduced coenzyme Q10, vitamin C and ethylenediaminetetracetic acid for example |
| 04/29/2008 | US7364749 Preventing scar tissue formation on the trachea, bonchi or alveoli by administering liposomes containing povidone iodine along with an antiinflammatory agent, anesthetic, antioxidant, antibiotic, or corticoid |
| 04/29/2008 | US7364748 Implantable device coated with graft polymer whose main chain has different solubility characteristics than side chains; uniform in situ dosing of water soluble medicants |
| 04/29/2008 | US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections |
| 04/29/2008 | US7364729 Method of inducing a CTL response |
| 04/29/2008 | US7364722 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 04/29/2008 | US7364675 Self-folding polymer microparticles |
| 04/29/2008 | US7364593 Prosthetic foot with tunable performance |
| 04/29/2008 | US7364568 Microneedle transdermal transport device |
| 04/29/2008 | US7364564 Implant having MEMS flow module with movable, flow-controlling baffle |
| 04/29/2008 | US7363928 Hyaluronate-based viscoelastic agent and low viscosity, chondroitin sulfate and hydroxypropylmethylcellulose-containing solution; for use in intr-articular therapy and as vitreous replacement in vitreo-retinal surgery |
| 04/29/2008 | CA2406798C Pharmaceutical parenteral composition containing a biphosphonate |
| 04/29/2008 | CA2351341C Collagen hemostatic foam |
| 04/29/2008 | CA2321461C Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 04/29/2008 | CA2316159C Prolonged release microcapsules |
| 04/29/2008 | CA2315329C Improved hmg coa reductase inhibitor extended release formulation |
| 04/29/2008 | CA2312990C Novel salts of metformin and method |
| 04/29/2008 | CA2309178C Topical compositions for nsai drug delivery |
| 04/29/2008 | CA2305331C Methods for decreasing the frequency of transmission of viral and for preventing and treating bacterial infections using cellulose acetate phthalate or hyroxypropyl methylcellulose phthalate excipients |
| 04/29/2008 | CA2297756C Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
| 04/29/2008 | CA2294756C Cross-linked polysaccharide drug carrier |
| 04/29/2008 | CA2271944C Formulation for electrically assisted delivery of lidocaine and epinephrine |
| 04/29/2008 | CA2220135C Medical device adhering to the skin |
| 04/29/2008 | CA2164845C Methods of preparing gas and gaseous precursor-filled microspheres |
| 04/25/2008 | CA2602078A1 Acute and chronic heartburn composition and method |
| 04/24/2008 | WO2008049043A2 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | WO2008049042A2 Ophthalmic compositions containing diglycine |
| 04/24/2008 | WO2008049020A2 Diclofenac gel |
| 04/24/2008 | WO2008048957A1 Process for preparing oxymorphone, naltrexone, and buprenorphine |
| 04/24/2008 | WO2008048874A2 Method of weight control employing chewing gum |
| 04/24/2008 | WO2008048802A1 Phenylalkyl carbamate compositions |
| 04/24/2008 | WO2008048801A2 Phenylalkylamino carbamate compositions |
| 04/24/2008 | WO2008048727A2 Wound dressings containing complexes of transition metals and alginate for elastase-sequestering |
| 04/24/2008 | WO2008048468A1 Formation of medically useful gels comprising microporous particles and methods of use |
| 04/24/2008 | WO2008048387A2 Stimulus-release carrier, methods of manufacture and methods of treatment |
| 04/24/2008 | WO2008048298A2 Polymer particles for delivery of macromolecules and methods of use |
| 04/24/2008 | WO2008048288A2 Novel nanoparticles and use thereof |
| 04/24/2008 | WO2008048211A2 Nano-scale devices |
| 04/24/2008 | WO2008048205A2 Method for delivering hydrophobic drugs via nanocrystal formulations |
| 04/24/2008 | WO2008048018A1 A pharmaceutically stable suspension of megestrol material |
| 04/24/2008 | WO2008047863A1 Sustained release preparation for tissue regeneration therapy |
| 04/24/2008 | WO2008047857A1 METHOD OF PRODUCING COMPOSITION COMPRISING HARDLY WATER-SOLUBLE COMPOUND ENCLOSED IN HYDROPHILIC MATRIX AND PREPARATION FOR EXTERNAL USE COMPRISING ANTICANCER AGENT OR DRUG HAVING OCTANOL/WATER PARTITION COEFFICIENT (Log P) OF -3.0 OR MORE BUT NOT MORE THAN 3.0 ENCLOSED IN HYDROPHILIC BASE |
| 04/24/2008 | WO2008047559A1 Highly water-dispersible powder and method of producing the same |
| 04/24/2008 | WO2008047548A1 Metal-containing fine particle |
| 04/24/2008 | WO2008047391A1 Nutriceutic composition comprising lactoferrin and proteasic probiotics |
| 04/24/2008 | WO2008047320A2 Multiple unit tablet compositions of benzimidazole compounds |
| 04/24/2008 | WO2008047239A2 Stable aerosol pharmaceutical formulations |
| 04/24/2008 | WO2008047208A1 Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid |
| 04/24/2008 | WO2008047201A2 Solid dispersion comprising a poorly water soluble drug |
| 04/24/2008 | WO2008047163A1 Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
| 04/24/2008 | WO2008047149A1 Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |
| 04/24/2008 | WO2008046905A1 Micellar nanoparticles of chemical substances |
| 04/24/2008 | WO2008046799A2 Preparation of granules of hydrophilic vitamins |
| 04/24/2008 | WO2008046625A2 Encapsulation of heat and moisture sensitive substances |
| 04/24/2008 | WO2008046617A1 Escitalopram and solid pharmaceutical composition comprising the same |
| 04/24/2008 | WO2008046606A2 Topical composition for the treatment of eczema |
| 04/24/2008 | WO2008046603A2 Adhesive label with bittering agent and fluidifying agents for natural airway secretions |
| 04/24/2008 | WO2008046407A2 Use of deuterium dioxide for treating hyperproliferative skin diseases |
| 04/24/2008 | WO2008046307A1 Method for inhibiting cancer using arsenic trioxide |
| 04/24/2008 | WO2008046299A1 Method for inhibiting cancer using arsenic trioxide |
| 04/24/2008 | WO2008046211A1 Methods and devices for the delivery of therapeutic gases including nitric oxide |
| 04/24/2008 | WO2008030512A3 Polystyrene sulfonate polymer tablets, their preparation and use |
| 04/24/2008 | WO2008027600A3 Imatinib compositions |
| 04/24/2008 | WO2008025563A3 Polymer matrix, method for its production, and its use |
| 04/24/2008 | WO2008023184A3 Solid dosage form |